Studies suggest improved delivery systems may enhance alpha-arbutin's transdermal bioavailability and depigmenting efficacy compared to conventional formulations
The glucagon-like peptide-1 receptor agonists (GLP-1 RAs), and now next-generation multi-agonists that include GLP-1 activity, are producing average weight reductions far larger than previously expected from drugs, reshaping clinical practice and how clinicians and patients think about obesity treatment
It provides a dual benefit of blood sugar control and cardiovascular protection
Patients often report feeling more energetic, motivated, and confident, which can encourage them to maintain healthier habits
Natural approaches, foods, and supplements can mimic and activate glucagon-like peptide-1 function, also known as GLP-1 agonists
oxyphylla also contains yakuchinone A (1-[4-hydroxy-3-methoxyphenyl]-7-phenyl-3-heptanone) and yakuchinone B (1-[4-hydroxy-3-methoxyphenyl]-7-phenylhept-1-en-3-one) reported to stimulate apoptosis in HL-60 cells (Jha et al., 2015)